Bristol-Myers Squibb CompanyBMYNYSE
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank3
Year-over-Year Change
Year-over-year operating income growth rate
Latest
-61.01%
↓ 278% vs avg
Percentile
P3
Near historical low
Streak
3 qtr
Consecutive declineDecelerating
Average
34.19%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -61.01% |
| Q3 2025 | -11.61% |
| Q2 2025 | 16.93% |
| Q1 2025 | 39.11% |
| Q4 2024 | 10.62% |
| Q3 2024 | -11.46% |
| Q2 2024 | 68.34% |
| Q1 2024 | -21.36% |
| Q4 2023 | -7.22% |
| Q3 2023 | 8.29% |
| Q2 2023 | -20.79% |
| Q1 2023 | 43.12% |
| Q4 2022 | -23.14% |
| Q3 2022 | -17.07% |
| Q2 2022 | -0.81% |
| Q1 2022 | 21.35% |
| Q4 2021 | 28.98% |
| Q3 2021 | 11.17% |
| Q2 2021 | -29.09% |
| Q1 2021 | 200.55% |
| Q4 2020 | -46.49% |
| Q3 2020 | 45.47% |
| Q2 2020 | 1.19% |
| Q1 2020 | 32.38% |
| Q4 2019 | -61.10% |
| Q3 2019 | -10.70% |
| Q2 2019 | 13.18% |
| Q1 2019 | 12.14% |
| Q4 2018 | -5.19% |
| Q3 2018 | 200.00% |
| Q2 2018 | -59.87% |
| Q1 2018 | 35.37% |
| Q4 2017 | -3.29% |
| Q3 2017 | -29.16% |
| Q2 2017 | -7.00% |
| Q1 2017 | 61.99% |
| Q4 2016 | -25.32% |
| Q3 2016 | 17.52% |
| Q2 2016 | 2.07% |
| Q1 2016 | 949.62% |